Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials
ENI with UHRT resulted in similar oncologic outcomes to CFRT ENI with prostate CFRT/MHRT, with worse acute grade ≥ 2 GU toxicity but no differences in late toxicity. Randomized phase 3 trials of ENI using UHRT techniques are much anticipated.
Authors
- Gerard Morton (ORCID: https://orcid.org/0000-0002-4903-1233)
- Stanley K. Liu (ORCID: https://orcid.org/0000-0001-6851-0857)
- Rachel Glicksman (ORCID: https://orcid.org/0000-0002-0555-8754)
- Melanie Davidson (ORCID: https://orcid.org/0000-0002-0587-6840)
- Ewa Szumacher
- Chia‐Lin Tseng (ORCID: https://orcid.org/0000-0002-3700-0886)
- Hans T. Chung (ORCID: https://orcid.org/0000-0002-9701-5406)
- Danny Vesprini (ORCID: https://orcid.org/0000-0001-9714-2782)
- William Chu (ORCID: https://orcid.org/0000-0002-9307-0184)
- Liying Zhang (ORCID: https://orcid.org/0000-0001-8520-267X)
- Andrea Deabreu
- Alexandre Mamedov
- Patrick Cheung
- Andrew Loblaw
Institutions
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- University of Toronto (CA)
- Kelowna General Hospital (CA)
- Health Sciences Centre (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.ctro.2024.100843
- Citations
- 5
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Sanofi